|
|
|
30.03.26 - 22:36
|
Humana Inc. to Release First Quarter 2026 Results on April 29, 2026 (Business Wire)
|
|
|
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the first quarter 2026 (1Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.
A webcast of the 1Q26 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/.
If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BId1413c4c078343e28841e18c372f7b58.
Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique registrant ID.
The company suggests participants listening via the web or the conference call sign in or dial in at least 15 mi...
|
|
|
30.03.26 - 19:12
|
Sun Life U.S. names Tony Mollica as new dental business leader (PR Newswire)
|
|
|
Former Humana executive to lead all of Sun Life U.S. Dental, focused on growth and promoting improved oral health for all WELLESLEY, Mass., March 30, 2026 /PRNewswire/ -- Sun Life U.S. today announced the appointment of Tony Mollica as president for its Dental business, which includes......
|
|
|
|
|
|
|
|
|
|
|
11.03.26 - 13:09
|
EO Care Appoints William Fleming and Kristi Savacool to Board of Directors, Reinforcing Its Leadership in Clinically Guided Cannabinoid Symptom Management (Business Wire)
|
|
|
Former Humana and Aon Hewitt executives join as directors and investors amid accelerating clinical validation, reimbursement expansion, and national growth.BOSTON--(BUSINESS WIRE)--EO Care, Inc., a leading provider of clinically guided cannabinoid-based symptom management, today announced the appointment of William Fleming, PharmD, and Kristi Savacool to its Board of Directors. Both join as directors and investors, further strengthening the company's governance, strategic depth, and national influence as cannabinoid care advances into mainstream healthcare delivery.
The appointments reflect EO Care's leadership at a defining moment for the industry—marked by accelerating clinical validation, expanding reimbursement pathways, and growing demand from providers and health plans seeking accountable alternatives for complex symptom management.
With the addition of Dr. Fleming and Ms. Savacool, EO Care's Board of Directors and advisory leadership now include former U.S. Surgeon General Dr. Regina Benjamin ...
|
|
|
|
|
|
|
09.03.26 - 22:03
|
Humana Completes Aggregate $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering (Business Wire)
|
|
|
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 6.625 percent of the principal amount (the “Junior Subordinated Notes Offering”).
The company expects net proceeds from the Junior Subordinated Notes Offering will be approximately $986 million after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Junior Subordinated Notes Offering for general corporate purposes, which may include the repayment of existing indebtedness, including borrowings under its commercial paper program.
Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC acted as active joint book-running managers for the Junior Subordinated Notes Offering.
The Junior Subordinated Notes Offering was made p...
|
|
|
|
|
06.03.26 - 17:06
|
AM Best Assigns Issue Credit Rating to Humana Inc.′s New Junior Subordinated Notes (Business Wire)
|
|
|
OLDWICK, N.J.--(BUSINESS WIRE)--#insurance--AM Best has assigned a Long-Term Issue Credit Rating of “bbb-” (Good) to the $1 billion, 6.625% fixed rate junior subordinated notes, due 2056, of Humana Inc. (Humana) (headquartered in Louisville, KY) [NYSE: HUM]. The outlook assigned to this Credit Rating (rating) is stable. All other ratings of Humana and its subsidiaries remain unchanged.
Humana expects to use the proceeds from the junior subordinated notes issuance for general corporate purposes, which may include repayment of existing indebtedness, including borrowings under its commercial paper program. AM Best expects the issuance to increase financial leverage slightly in the intermediate term. The company's financial leverage, as measured by AM Best, will increase slightly from year-end 2025 to approximately 41.8% with the new issuance. Financial leverage has exceeded the organization's long-term target debt-to-capital ratio of 40%, but management expects to manage to this target through increase...
|
|
|
|
|
06.03.26 - 01:12
|
Humana Prices $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering (Business Wire)
|
|
|
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the “Junior Subordinated Notes Offering”). The Junior Subordinated Notes Offering is expected to close on March 9, 2026, subject to the satisfaction of customary closing conditions.
The company expects net proceeds from the Junior Subordinated Notes Offering will be approximately $986 million after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Junior Subordinated Notes Offering for general corporate purposes, which may include the repayment of existing indebtedness, including borrowings under its commercial paper program.
Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc. and Wells Fargo Securities, L...
|
|
|
03.03.26 - 15:06
|
Humana Foundation Increases Investment to Help End the Veteran Suicide Crisis (Business Wire)
|
|
|
Commits $5 million to Face the Fight® and Hosts Second Annual Coalition MeetingLOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 45 years, today announced an expanded commitment to Face the Fight®, a national, cross‑sector initiative dedicated to dramatically reducing veteran suicide. As a founding partner, the Foundation will invest $5 million to scale evidence informed solutions, strengthen data collection efforts, and expand support for community-based organizations serving veterans at high risk of suicide. This builds on the Foundation's initial three-year, $6 million philanthropic commitment. To date, Face the Fight® has made tremendous progress, reaching over one million veterans, service members, and family members with suicide prevention, connection, early-intervention strategies, and training.
Face the Fight®, launched in 2023 and founded by USAA, the Humana Foundation and Reach Resilience, unites organizations nationwide to advance ...
|
|
|
|
|
|
|
|
|
|
|
19.02.26 - 12:33
|
Humana Board Declares Payment of Quarterly Dividend to Stockholders (Business Wire)
|
|
|
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 24, 2026 to stockholders of record as of the close of business on March 27, 2026.
About Humana
Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com. Contacts
Lisa Stoner
Humana Investor Relations
(502) 580-2652
e-mail: lstamper@humana.com
Mark Taylor
Humana Corporate Communications
(317) 753-0345
e-mail: Mtaylor108@humana.com...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
